---
title: "\"Performance\" ADICON HOLDINGS annual net profit of 18.44 million RMB fell by more than 60%, no dividend declared"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280439733.md"
description: "ADICON HOLDINGS announced its full-year results for the year ended December last year, with revenue of RMB 2.638 billion, a year-on-year decrease of 9.5%. Net profit was RMB 18.443 million, a year-on-year decrease of 60.8%; earnings per share were RMB 0.03. No dividend was declared"
datetime: "2026-03-25T08:36:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280439733.md)
  - [en](https://longbridge.com/en/news/280439733.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280439733.md)
---

# "Performance" ADICON HOLDINGS annual net profit of 18.44 million RMB fell by more than 60%, no dividend declared

ADICON HOLDINGS (09860.HK) announced its full-year results for the year ended last December, with revenue of RMB 2.638 billion, a year-on-year decrease of 9.5%. Net profit was RMB 18.443 million, a year-on-year decrease of 60.8%; earnings per share were RMB 0.03. No dividend was declared

### Related Stocks

- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [512170.CN](https://longbridge.com/en/quote/512170.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [159883.CN](https://longbridge.com/en/quote/159883.CN.md)
- [09860.HK](https://longbridge.com/en/quote/09860.HK.md)
- [08341.HK](https://longbridge.com/en/quote/08341.HK.md)
- [562600.CN](https://longbridge.com/en/quote/562600.CN.md)

## Related News & Research

- [ADICON Delays Shareholder Circular as Crown Bioscience Deal Awaits Regulatory Approvals](https://longbridge.com/en/news/286253929.md)
- [Broncus shareholders back all AGM resolutions, update articles of association](https://longbridge.com/en/news/286439966.md)
- [Manulife Singapore to offer multi-cancer blood test starting May](https://longbridge.com/en/news/286710691.md)
- [Basecare Wins NMPA Class III Approval for Gems Embryo Culture Medium](https://longbridge.com/en/news/286258287.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)